GlassScriptPhysician profile
Lawrence Sigler
NPI 1063581874
$4,902.68
in general payments reported to CMS, 2019-2025
29 companies · $914 in 2025
The $914 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $186 · 2021: $457 · 2022: $808 · 2023: $1,073 · 2024: $724 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,711.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,062.03 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $710.46 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $573.69 | 2019-2024 | Xtandi, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $524.74 | 2019-2025 | |
| Tolmar, INC. | $250.02 | 2024-2025 | Eligard, Jatenzo |
| Antares Pharma, INC. | $249.07 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Dendreon Pharmaceuticals LLC | $195.21 | 2019-2023 | Provenge |
| Pfizer INC. | $191.21 | 2021-2025 | |
| Urovant Sciences INC | $161.17 | 2022 | |
| Merck Sharp & Dohme LLC | $160.13 | 2022-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Procept Biorobotics Corporation | $150.00 | 2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $112.26 | 2019-2023 | Xiaflex, Edex, Aveed |
| Photocure INC | $59.70 | 2019-2022 | |
| Axonics, INC. | $51.74 | 2023 | Bulkamid |
| Verity Pharmaceuticals INC. | $51.63 | 2025 | Trelstar |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $48.14 | 2021-2022 | |
| Blue Earth Diagnostics | $45.38 | 2019-2021 | |
| Neotract INC. | $41.97 | 2019 | |
| Janssen Scientific Affairs, LLC | $33.18 | 2019 | |
| Dentsply Ih INC. | $32.41 | 2021-2022 | |
| Urogen Pharma, INC. | $24.50 | 2023 | Jelmyto |
| Dentsply Ih Ab | $24.41 | 2024 | Lofric |
| Olympus America INC. | $23.74 | 2024 | Itind System |
| Accord Healthcare, INC. | $23.10 | 2025 | |
| Endo USA, INC. | $22.53 | 2025 | Aveed, Xiaflex |
| Teleflex LLC | $22.38 | 2021 | |
| Progenics Pharmaceuticals, INC. | $21.59 | 2023 | Pylarify |
| Allergan, INC. | $18.73 | 2019 | |
| Halozyme INC | $17.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Sigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.